240-week Entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C. Xu JH, Fan YN, Yu YY, Si CW, et al. J Viral Hepat 2022 Jun 23. doi: 10.1111/jvh.13724.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu JH, Fan YN, Yu YY, Si CW, et al. 240-week Entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C. J Viral Hepat 2022 Jun 23. doi: 10.1111/jvh.13724.
PMID: 35737855